Bio Solution Co.,Ltd.

₩4,650As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:086820Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (7.89%)
Div yield —
ROE 2.50%
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.08)
PE TTM 132.0
TSR TTM (42.24%)
Mkt cap ₩120.0B
ROIC (3.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,675
0.53%
(19.83%)
Hold 6|9|7|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
101.05
103.51
101.12
105.98
19.63%
22.83%
15.15%
14.23%
Revenue₩B
10.95
11.28
11.05
11.35
0.84%
5.96%
3.53%
2.77%
Peers (US$88.47M)
Cap (US$)
PE
88.81M
—
83.39M
—
Capital
TTM
5Y
10Y
Leveragex
0.093
0.460
0.426
EBIT/Intx
1.294
0.671
0.617
Own earn%
191.11
(66.93)
(84.22)
Sh yield%
21.20
38.35
38.42
Owners
Insiders/Inst%
13.32
48.33
Short interest%
1.38
SBC / revenue%
3.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
26–30
$1 testx
0.5
Incr. ROIC%
6